BioSpace News Archive

Promis Diagnostics, Inc., a molecular diagnostics company focused on early cancer diagnosis, recently presented clinical validation data for CystoChek, its proprietary urine-based DNA methylation test of PENK for bladder cancer detection in hematuria, at the 2021 American Urological Association Annual Meeting.

Bristol Myers Squibb announced findings from a global real-world evidence study that the risk of mortality increases with worse New York Heart Association functional class for patients with obstructive hypertrophic cardiomyopathy.